In fact, while the paper by Dias and colleagues clearly indicates that GLS2 overexpression elevates mesenchymal markers in several breast cancer cell lines [79], a study by Ramirez-Peña and colleagues demonstrated that GLS2 expression is inversely correlated with EMT in breast cancer [81]. Here, GLS2 is linked to breast cancer.